D. Boral Capital reaffirmed their buy rating on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a research report released on Friday,Benzinga reports. The firm currently has a $30.00 target price ...
Asian News International on MSN7d
Biological E Limited partners with Bavarian Nordic to increase global access to Chikungunya VaccineBiological E Limited (BE) on Tuesday announced a strategic partnership with Bavarian Nordic A/S (OMX: BAVA) to expand access ...
First chikungunya vaccine approved in Europe for persons as young as 12 years old. On track for launch in key European ...
Medpage Today on MSN13d
Will the Egg Shortage Affect Flu Shots?Previous bird flu outbreaks and decades-old public health infrastructure have led industry to protect the hens used for ...
Hyderabad: Biopharma player Biological E (BE) entered into a strategic partnership with Danish vaccine maker Bavarian Nordic ...
ImmunityBio, Inc.’s IBRX share price has surged by 15.03%, which has investors questioning if this is right time to sell.
The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for ...
Hyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian ...
7d
Biological E partners with Bavarian Nordic to expand access to Chikungunya Vaccine in low- and middle-income countries.
This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback